Corton Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Buy |
27,137
+14,172
| +109% | +$133K | 0.3% | 127 |
|
|
2025
Q1 | $92.2K | Buy |
+12,965
| New | +$92.2K | 0.3% | 136 |
|
|
2024
Q3 | – | Sell |
-19,535
| Closed | -$437K | – | 606 |
|
|
2024
Q2 | $437K | Buy |
19,535
+10,813
| +124% | +$242K | 0.23% | 73 |
|
|
2024
Q1 | $240K | Sell |
8,722
-1,464
| -14% | -$40.3K | 0.09% | 352 |
|
|
2023
Q4 | $311K | Sell |
10,186
-3,902
| -28% | -$119K | 0.1% | 308 |
|
|
2023
Q3 | $445K | Buy |
14,088
+6,740
| +92% | +$213K | 0.22% | 118 |
|
|
2023
Q2 | $300K | Buy |
7,348
+741
| +11% | +$30.2K | 0.14% | 214 |
|
|
2023
Q1 | $246K | Buy |
+6,607
| New | +$246K | 0.17% | 185 |
|